Cancer: From Genomics to Pharmaceutics

Published

Sábháilte in:
Sonraí bibleagrafaíochta
Formáid: Online
Teanga:Béarla
Foilsithe / Cruthaithe: Istanbul University Press 2024
Ábhair:
Rochtain ar líne:https://directory.doabooks.org/handle/20.500.12854/146125
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
_version_ 1869514335198380032
collection Directory of Open Access Books
description Published
format Online
id doab-20.500.12854ir-146125
institution Directory of Open Access Books
language eng
publishDate 2024
publishDateRange 2024
publishDateSort 2024
publisher Istanbul University Press
publisherStr Istanbul University Press
record_format ojs
spelling doab-20.500.12854ir-1461252024-10-09T11:03:50Z Cancer: From Genomics to Pharmaceutics Karakas, Zeynep Erdal, Meryem Sedef Sayitoglu, Muge Soluk Tekkesin, Merva thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFN Medical genetics thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Published Cancer is a devastating disease that affects millions of people worldwide, causing significant morbidity and mortality. With the development of new technologies and the abundance of genomic data available, researchers can better understand the genetic causes of cancer and develop targeted therapies. Recent research on cancer genome data has altered our understanding of the hallmarks of cancer due to the discovery of novel malignant transformation mechanisms. The integration and analysis of big genomic data have provided new insights into the evolution of cancer, metastasis mechanisms, and germline predisposition to cancer. Results of international genome projects opened a new window to transcribed genomic regions and the noncoding RNA world. Additionally genome editing approaches are now in use in clinics and giving scientists the ability to change the genetic material not only for Mendelian type of genetic disorders as well as cancer. This book, entitled Cancer: From Genomics to Pharmaceutics, is a part of the ‘100 e-books project on the 100th Anniversary of the Republic of Turkey’ designed by ˙Istanbul University. The aim of the book is to provide a comprehensive overview of the latest developments in cancer research, focusing on the intersection of genomics and pharmaceuticals as well as to increase the academic co-operation between PhD candidates and supervisors that all chapters are co-written by PhD candidates and their supervisors. This book is intended for researchers, clinicians, students, and anyone interested in the latest developments in cancer research. It is designed to provide a comprehensive overview and to serve as a valuable resource for those working in the field. We hope that this book will contribute to the recent knowledge and attention of cancer research. 2024-10-09T11:03:40Z 2024-10-09T11:03:40Z 2024-08-19 book 978-605-07-1621-4 https://directory.doabooks.org/handle/20.500.12854/146125 eng image/png Attribution-NonCommercial 4.0 International https://iupress.istanbul.edu.tr/en/book/cancer-from-genomics-to-pharmaceutics/home Istanbul University Press 10.26650/B/LSB28LSB48LSB56.2024.019 Cancer is a devastating disease that affects millions of people worldwide, causing significant morbidity and mortality. With the development of new technologies and the abundance of genomic data available, researchers can better understand the genetic causes of cancer and develop targeted therapies. Recent research on cancer genome data has altered our understanding of the hallmarks of cancer due to the discovery of novel malignant transformation mechanisms. The integration and analysis of big genomic data have provided new insights into the evolution of cancer, metastasis mechanisms, and germline predisposition to cancer. Results of international genome projects opened a new window to transcribed genomic regions and the noncoding RNA world. Additionally genome editing approaches are now in use in clinics and giving scientists the ability to change the genetic material not only for Mendelian type of genetic disorders as well as cancer. This book, entitled Cancer: From Genomics to Pharmaceutics, is a part of the ‘100 e-books project on the 100th Anniversary of the Republic of Turkey’ designed by ˙Istanbul University. The aim of the book is to provide a comprehensive overview of the latest developments in cancer research, focusing on the intersection of genomics and pharmaceuticals as well as to increase the academic co-operation between PhD candidates and supervisors that all chapters are co-written by PhD candidates and their supervisors. This book is intended for researchers, clinicians, students, and anyone interested in the latest developments in cancer research. It is designed to provide a comprehensive overview and to serve as a valuable resource for those working in the field. We hope that this book will contribute to the recent knowledge and attention of cancer research. 10.26650/B/LSB28LSB48LSB56.2024.019 da550c22-aaad-4944-aa07-c3e294b4c6e9 978-605-07-1621-4 302 Istanbul, Turkiye open access
spellingShingle thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFN Medical genetics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Cancer: From Genomics to Pharmaceutics
title Cancer: From Genomics to Pharmaceutics
title_full Cancer: From Genomics to Pharmaceutics
title_fullStr Cancer: From Genomics to Pharmaceutics
title_full_unstemmed Cancer: From Genomics to Pharmaceutics
title_short Cancer: From Genomics to Pharmaceutics
title_sort cancer from genomics to pharmaceutics
topic thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFN Medical genetics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
topic_facet thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFN Medical genetics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
url https://directory.doabooks.org/handle/20.500.12854/146125